fiscal year 2013 to 2022; the company’s fiscal year starts on April 1 of the stated year and ends on March 31 of the following year
Special properties
consolidated data of Takeda Pharmaceutical Co., Ltd. and its subsidiaries
Supplementary notes
Takeda has adopted International Financial Reporting Standards (IFRS) from fiscal 2013 and the disclosure information in this material is based on IFRS. According to this adoption, the previous year's information is also based on IFRS.
Figures prior to fiscal 2021 come from previous reporting.
reporting. Figures have been rounded. 100 Japanese yen equal 0.71 U.S. dollars or 0.64 euros as of January 2024.
In fiscal year 2202, the Japanese pharmaceutical company Takeda Pharmaceutical Co., Ltd. recorded R&D expenses of approximately *** billion Japanese yen. The company focuses mainly on the therapeutic areas of oncology, gastroenterology, and neuroscience.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Takeda Pharmaceutical Company. (June 28, 2023). Research and development expenses of Takeda Pharmaceutical Co., Ltd. from fiscal year 2013 to 2022 (in billion Japanese yen) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 23, 2026, from /statistics/797062/takeda-pharmaceutical-research-and-development-expenses/
Takeda Pharmaceutical Company. "Research and development expenses of Takeda Pharmaceutical Co., Ltd. from fiscal year 2013 to 2022 (in billion Japanese yen)." Chart. June 28, 2023. ÌÇÐÄÆƽâ°æ. Accessed July 23, 2026. /statistics/797062/takeda-pharmaceutical-research-and-development-expenses/
Takeda Pharmaceutical Company. (2023). Research and development expenses of Takeda Pharmaceutical Co., Ltd. from fiscal year 2013 to 2022 (in billion Japanese yen). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 23, 2026. /statistics/797062/takeda-pharmaceutical-research-and-development-expenses/
Takeda Pharmaceutical Company. "Research and Development Expenses of Takeda Pharmaceutical Co., Ltd. from Fiscal Year 2013 to 2022 (in Billion Japanese Yen)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 28 Jun 2023, /statistics/797062/takeda-pharmaceutical-research-and-development-expenses/
Takeda Pharmaceutical Company, Research and development expenses of Takeda Pharmaceutical Co., Ltd. from fiscal year 2013 to 2022 (in billion Japanese yen) ÌÇÐÄÆƽâ°æ, /statistics/797062/takeda-pharmaceutical-research-and-development-expenses/ (last visited July 23, 2026)
Research and development expenses of Takeda Pharmaceutical Co., Ltd. from fiscal year 2013 to 2022 (in billion Japanese yen) [Graph], Takeda Pharmaceutical Company, June 28, 2023. [Online]. Available: /statistics/797062/takeda-pharmaceutical-research-and-development-expenses/
